Used primarily as a key intermediate in pharmaceutical synthesis, especially in the development of bioactive molecules and drug candidates. Its boron-containing group enables participation in Suzuki-Miyaura cross-coupling reactions, a widely used method in forming carbon-carbon bonds in medicinal chemistry. The compound's rigid azabicyclic scaffold contributes to structural stability and influences selectivity in receptor binding, making it valuable in the design of central nervous system agents and other therapeutic compounds. The tert-butyl protecting group allows for controlled reactivity during multi-step syntheses, enhancing compatibility with various reaction conditions.